Newsweek.com's New & Noteworthy helps consumers discover great new products including health and beauty, a prickleback chaser ...

Approval of the topical aryl hydrocarbon receptor agonist was supported by the pivotal ADORING studies. In the ...

Another big win for Lilly this year came when the FDA approved its eczema drug, Ebglyss. The eczema market is more crowded than Alzheimer's disease and weight loss. But what makes Ebglyss a ...

In a review of the condition and associated drug development opportunities, GlobalData describes chronic hand eczema (CHE) as ...

Parents of children with eczema are more likely to be short on sleep and to use medication to try to get more of it, a ...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

Living with eczema is more than just occasional flare-ups. It’s an ongoing struggle with relentless itching, redness, and ...

We’ve rounded up the best dermatologist-approved, fragrance-free moisturizers for your psoriasis skin care routine.

It's still early science -- studies in mice and in human cells -- but researchers are on the trail of an effective new treatment for inflammatory skin conditions such as rosacea. Skin cells called ...